Literature DB >> 21510771

Symptoms, comorbidities, and health care in advanced chronic obstructive pulmonary disease or chronic heart failure.

Daisy J A Janssen1, Martijn A Spruit, Nicole H Uszko-Lencer, Jos M G A Schols, Emiel F M Wouters.   

Abstract

BACKGROUND: Patients with advanced chronic obstructive pulmonary disease (COPD) or chronic heart failure (CHF) may experience significant symptom distress. For development of palliative care programs that adequately address symptoms of patients with COPD or CHF, it is necessary to know severity of symptom distress and to gain insight in comorbidities and current provision of health care. Objective of the present cross-sectional observational study was to assess severity of symptoms, presence of comorbidities, and current provision of health care in outpatients with advanced COPD or CHF.
METHODS: A total of 105 outpatients with clinically stable but advanced COPD (Global initiative for chronic Obstructive Lung Disease [GOLD] stage III or IV) and 80 patients with advanced CHF (New York Heart Association [NYHA] class III or IV) were assessed for demographics, clinical characteristics, self-reported comorbidities, and severity of symptoms using visual analogue scales. In addition, current health care and symptom-related interventions have been assessed.
RESULTS: Comorbidities were reported by 96.3% of the CHF patients and 61.9% of the COPD patients. Patients suffered from multiple symptoms, like dyspnea, fatigue, muscle weakness, coughing, low mood, sleeplessness, and frequent micturition. For most symptoms, only the minority of patients had received symptom-related treatment. Involvement of allied health care professionals was low. The majority of COPD and CHF patients had received home adaptation and medical aids.
CONCLUSIONS: Patients with advanced COPD or CHF experience comorbidities and suffer from multiple symptoms, which are often under treated. Further development and implementation of palliative care programs, consisting of regular assessment of the patients' comorbidities and symptoms as well as the provision of patient-tailored interventions is needed.

Entities:  

Mesh:

Year:  2011        PMID: 21510771     DOI: 10.1089/jpm.2010.0479

Source DB:  PubMed          Journal:  J Palliat Med        ISSN: 1557-7740            Impact factor:   2.947


  51 in total

1.  Demographic and clinical characteristics associated with quality of life in patients with chronic obstructive pulmonary disease.

Authors:  Signe Berit Bentsen; Christine Miaskowski; Tone Rustøen
Journal:  Qual Life Res       Date:  2013-09-03       Impact factor: 4.147

2.  Treatment Approaches to Congestion Relief in Acute Decompensated HF: Insights After DOSE-AHF and CARRESS-HF.

Authors:  Simon F Shakar; JoAnn Lindenfeld
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-08

3.  Burdensome Physical and Depressive Symptoms Predict Heart Failure-Specific Health Status Over One Year.

Authors:  Hillary D Lum; Evan P Carey; Diane Fairclough; Mary E Plomondon; Evelyn Hutt; John S Rumsfeld; David B Bekelman
Journal:  J Pain Symptom Manage       Date:  2016-02-26       Impact factor: 3.612

4.  Clustering of patients with end-stage chronic diseases by symptoms: a new approach to identify health needs.

Authors:  Panaiotis Finamore; Martijn A Spruit; Jos M G A Schols; Raffaele Antonelli Incalzi; Emiel F M Wouters; Daisy J A Janssen
Journal:  Aging Clin Exp Res       Date:  2020-04-11       Impact factor: 3.636

Review 5.  Optimizing quality of life in patients with idiopathic pulmonary fibrosis.

Authors:  Mirjam J G van Manen; J J Miranda Geelhoed; Nelleke C Tak; Marlies S Wijsenbeek
Journal:  Ther Adv Respir Dis       Date:  2017-01-01       Impact factor: 4.031

6.  The Associations of Diagnoses of Fatigue and Depression With Use of Medical Services in Patients With Heart Failure.

Authors:  Seongkum Heo; Jean McSweeney; Pao-Feng Tsai; Songthip Ounpraseuth; Debra K Moser; JinShil Kim
Journal:  J Cardiovasc Nurs       Date:  2019 Jul/Aug       Impact factor: 2.083

7.  Outpatient palliative care for chronic obstructive pulmonary disease: a case series.

Authors:  Clara Schroedl; Susan Yount; Eytan Szmuilowicz; Sharon R Rosenberg; Ravi Kalhan
Journal:  J Palliat Med       Date:  2014-06-16       Impact factor: 2.947

8.  Rationale and Design of the Randomized Evaluation of Default Access to Palliative Services (REDAPS) Trial.

Authors:  Katherine R Courtright; Vanessa Madden; Nicole B Gabler; Elizabeth Cooney; Dylan S Small; Andrea Troxel; David Casarett; Mary Ersek; J Brian Cassel; Lauren Hersch Nicholas; Gabriel Escobar; Sarah H Hill; Dan O'Brien; Mark Vogel; Scott D Halpern
Journal:  Ann Am Thorac Soc       Date:  2016-09

Review 9.  Inadequate Palliative Care in Chronic Lung Disease. An Issue of Health Care Inequality.

Authors:  Crystal E Brown; Nancy S Jecker; J Randall Curtis
Journal:  Ann Am Thorac Soc       Date:  2016-03

10.  Effect of Sustained-Release Morphine for Refractory Breathlessness in Chronic Obstructive Pulmonary Disease on Health Status: A Randomized Clinical Trial.

Authors:  Cornelia A Verberkt; Marieke H J van den Beuken-van Everdingen; Jos M G A Schols; Niels Hameleers; Emiel F M Wouters; Daisy J A Janssen
Journal:  JAMA Intern Med       Date:  2020-10-01       Impact factor: 21.873

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.